Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients
Status:
Recruiting
Trial end date:
2021-08-03
Target enrollment:
Participant gender:
Summary
A multi-center, randomized, controlled study to evaluate the effect of different doses of
roxadustate on hemoglobin target-met in peritoneal dialysis patients
Phase:
Phase 4
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Beijing Haidian Hospital Beijing Hospital of Traditional Chinese Medicine